Item 1A. Risk Factors
Item
1A. Risk Factors
As
of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our Annual Report
on Form 10-K filed with the SEC on March 28, 2025, except that we have identified the additional risk factors set forth below.
We
currently have a substantial number of shares of common stock subject to potential issuance associated with our Equity Line of Credit
(“ELOC”) with Lincoln Park Capital Fund, LLC (“Lincoln Park”). The issuance or sale of shares under our ELOC
would substantially increase the number of shares outstanding and result in dilution to our security holders. This might substantially
decrease the market price of our common stock.
We
have a substantial number of shares of our common stock that may be issued in the future. On June 23, 2025, we entered into a purchase
agreement (the “Purchase Agreement”) with Lincoln Park, pursuant to which Lincoln Park committed to purchase from us, from
time to time and subject to certain limitations and conditions, up to an aggregate of $20,000,000 of our common stock over the 24-month
term of the Purchase Agreement. On that date, we issued Lincoln Park 882,145 shares of our common stock. During the three months ended
September 30, 2025, we issued an additional 1,520,609 shares of our common stock to Lincoln Park under our ELOC. To the extent that shares
of common stock are issued or sold under our ELOC, dilution to our security holders may occur. The issuance of these additional securities
may have an adverse effect on the market price of our securities.
Failure
to comply with The Nasdaq Capital Market continued listing requirements may result in our common stock being delisted from The Nasdaq
Capital Market.
On
June 30, 2025, we received a deficiency letter (the “Notice”) from the Listing Qualifications Department of Nasdaq indicating
that, based upon the closing bid price of our common stock for 30 consecutive business days prior to the delivery of the Notice, we are
not in compliance with the bid price requirement, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”).
We were provided a compliance period of 180 calendar days from the date of the Notice, or until December 29, 2025, to regain compliance
with the Bid Price Requirement, pursuant to Nasdaq Listing Rule 5810(c)(3)(A).
We
will continue to monitor the closing bid price of our common stock and seek to regain compliance with all applicable Nasdaq requirements
within the allotted compliance periods and may, if appropriate, consider available options, including implementation of a reverse stock
split of our common stock, to regain compliance with the Bid Price Requirement. As previously disclosed in the preliminary information
statement filed on Schedule 14C filed on October 30, 2025, our stockholders have authorized our Board to implement a reverse stock split
in the range of 1-for-10 to 1-for-20. If we seek to implement a reverse stock split in order to remain listed on Nasdaq, the announcement
or implementation of such a reverse stock split could negatively affect the price of our common stock. If we do not regain compliance
within the allotted compliance periods, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that our common
stock will be subject to delisting. We would then be entitled to appeal that determination to a Nasdaq hearings panel. There can be no
assurance that we will regain compliance with the Bid Price Requirement during the 180-day compliance period or maintain compliance with
the other Nasdaq listing requirements. A delisting could substantially decrease trading in our common stock, adversely affect the market
liquidity of our common stock as a result of the loss of market efficiencies associated with Nasdaq and the loss of federal preemption
of state securities laws, adversely affect our ability to obtain financing on acceptable terms, if at all, and may result in the potential
loss of confidence by investors, suppliers, customers and employees and fewer business development opportunities.
30
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.